275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
When we set aside all the complexities involved in the drug development lifecycle and simply articulate the final goal, it is this: delivering effective treatments to patients in a timely manner. Patient access depends on marketing authorization and payer acceptance. Payer acceptance depends on scientific evidence that your compound addresses unmet needs and delivers differentiated value to patients. Regardless of indication or therapeutic area, irrespective of price or economics, the question of unmet need is at the heart of payer decision-making.
While developing supporting evidence is integral to achieving that goal, and ultimately, to commercial success, presenting the value case to payers happens near the end of the drug development lifecycle. The question often arises: Where is the right place to start?
The answer is to incorporate a pricing and market access strategy from the outset. When you begin the journey by focusing on unmet needs and ensuring that everyone on your team understands what problem you are trying to solve, that insight drives the process. Clinical trials are designed accordingly, and evidence generation is addressed with the end in mind. This process leads naturally to your value story.
Where can Parexel help in this journey? Everywhere.
Parexel offers cohesive alignment throughout development to support the global launch of reimbursable, appropriately priced, affordable medicines with our market access pricing. We can support you in determining:
It is never too early to consider access and reimbursement. Weaving commercial insights into the clinical and regulatory phases helps increase product valuation for investment, as well as prepare for a payer reimbursement strategy to support market access and return on investment. Parexel offers top-notch expertise in health economics and outcomes research (HEOR) to help you determine the right strategy and build the evidence package.
Learn about Parexel's industry-leading expertise in delivering every component of the evidence package by leveraging health economic modeling, evidence reviews, advanced analytics and Clinical Outcomes Assessments (COAs).
We are always available for a conversation.